PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress

Antioxidants and Redox Signaling

Volumn 20, Issue 9, 2014, Pages 1382-1395

  Wu, Yong ^a   Zhou, Hillary ^a   Wu, Ke ^b   Lee, Sangkyu ^a   Li, Ruijin ^a,c   Liu, Xuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WUHAN UNIVERSITY   (China)

^c SHANXI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; FATTY ACID; GLUTATHIONE PEROXIDASE 1; MAMMALIAN TARGET OF RAPAMYCIN; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; C57BL 6 MOUSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; MICE; NITRIC OXIDE; OXIDATIVE STRESS; PALMITIC ACID; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PTEN PHOSPHOHYDROLASE; REACTIVE OXYGEN SPECIES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84896835574     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5498     Document Type: Article

References (59)

1. Bashan N, Kovsan J, Kachko I, Ovadia H, and Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89: 27-71, 2009.
2. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, and Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353: 273-276, 1991.
3. Birle D, Bottini N, Williams S, Huynh H, de Belle I, Adamson E, and Mustelin T. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. J Immunol 169: 286-291, 2002.
4. Bode AM and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805, 2004.
5. Cai X and Liu X. Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage. Proc Natl Acad Sci U S A 105: 16958-16963, 2008.
6. Carlstrom M, Larsen FJ, Nystrom T, Hezel M, Borniquel S, Weitzberg E, and Lundberg JO. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci U S A 107: 17716-17720, 2010.
7. Chalupsky K and Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 102: 9056-9061, 2005.
8. Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR, and Wu H. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 28: 3281-3289, 2008.
9. Deleris P, Bacqueville D, Gayral S, Carrez L, Salles JP, Perret B, and Breton-Douillon M. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 278: 38884-38891, 2003.
10. Flohe L. Glutathione peroxidase. Basic Life Sci 49: 663-668, 1988.
11. Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, Jones J, Goldschmidt-Clermont PJ, and Loscalzo J. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 106: 1154-1158, 2002.
12. Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, and Loscalzo J. Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 282: H1255-H1261, 2002.
13. Formoso G, Chen H, Kim JA, Montagnani M, Consoli A, and Quon MJ. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase-and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol Endocrinol 20: 1153-1163, 2006.
14. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, and Wu H. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and-independent mechanisms. Cancer Cell 3: 117-130, 2003.
15. Grankvist K, Marklund SL, and Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 199: 393-398, 1981.
16. Haffner S and Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 108: 1541-1545, 2003.
17. Ignarro LJ, Cirino G, Casini A, and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34: 879-886, 1999.
18. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
19. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, and Yao TP. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340, 2001.
20. Jouven X, Charles MA, Desnos M, and Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104: 756-761, 2001.
21. Kang KH, Lemke G, and Kim JW. The PI3K-PTEN tug-ofwar, oxidative stress and retinal degeneration. Trends Mol Med 15: 191-198, 2009.
22. Kunjathoor VV, Wilson DL, and LeBoeuf RC. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97: 1767-1773, 1996.
23. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, and Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol 17: 64-71, 1997.
24. Lei XG, Cheng WH, and McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 27: 41-61, 2007.
25. Li AG, Piluso LG, Cai X, Gadd BJ, Ladurner AG, and Liu X. An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell 28: 408-421, 2007.
26. Li AG, Piluso LG, Cai X, Wei G, Sellers WR, and Liu X. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23: 575-587, 2006.
27. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
28. Li S, Yan T, Yang JQ, Oberley TD, and Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
29. Li WG, Miller FJ, Jr., Zhang HJ, Spitz DR, Oberley LW, and Weintraub NL. H(2)O(2)-induced O(2) production by a nonphagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276: 29251-29256, 2001.
30. Lian Z and Di Cristofano A. Class reunion: PTEN joins the nuclear crew. Oncogene 24: 7394-7400, 2005.
31. Liao F, Andalibi A, deBeer FC, Fogelman AM, and Lusis AJ. Genetic control of inflammatory gene induction and NFkappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91: 2572-2579, 1993.
32. Lin SJ, Shyue SK, Liu PL, Chen YH, Ku HH, Chen JW, Tam KB, and Chen YL. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogenactivated protein kinase pathways. J Mol Cell Cardiol 36: 129-139, 2004.
33. Liu B, Chen Y, and St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 44: 1529-1535, 2008.
34. Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J, and Yung WK. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 67: 11054-11063, 2007.
35. Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, and Chen J. WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol 13: 728-733, 2011.
36. Mercer J and Bennett M. The role of p53 in atherosclerosis. Cell Cycle 5: 1907-1909, 2006.
37. Ming XF, Montani JP, and Yang Z. Perspectives of targeting mTORC1-S6K1 in cardiovascular aging. Front Physiol 3: 5, 2012.
38. Mueller MA, Beutner F, Teupser D, Ceglarek U, and Thiery J. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/-mice despite severe hypercholesterolemia. Atherosclerosis 198: 39-48, 2008.
39. Paigen B, Ishida BY, Verstuyft J, Winters RB, and Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10: 316-323, 1990.
40. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, and LeBoeuf RC. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A 84: 3763-3767, 1987.
41. Paigen B, Morrow A, Holmes PA, Mitchell D, and Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68: 231-240, 1987.
42. Paravicini TM and Touyz RM. Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006.
43. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, and Pelicci PG. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210, 2000.
44. Planchon SM, Waite KA, and Eng C. The nuclear affairs of PTEN. J Cell Sci 121: 249-253, 2008.
45. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, and Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313, 2005.
46. Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, Bickel C, Cambien F, Tiret L, Munzel T, and Blankenberg S. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 45: 1631-1637, 2005.
47. Schreyer SA, Wilson DL, and LeBoeuf RC. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136: 17-24, 1998.
48. Shabek N and Ciechanover A. Degradation of ubiquitin: the fate of the cellular reaper. Cell Cycle 9: 523-530, 2010.
49. Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS, and Huber LJ. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 26: 28-38, 2006.
50. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, and Pandolfi PP. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455: 813-817, 2008.
51. Song MS, Salmena L, and Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296, 2012.
52. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, and Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610, 1996.
53. Tan M, Li S, Swaroop M, Guan K, Oberley LW, and Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061-12066, 1999.
54. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, and Pandolfi PP. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128: 141-156, 2007.
55. Wang L, Sapuri-Butti AR, Aung HH, Parikh AN, and Rutledge JC. Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H237-H244, 2008.
56. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, and Jiang X. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128: 129-139, 2007.
57. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, and Shen YH. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55: 2301-2310, 2006.
58. Wu Y, Song P, Xu J, Zhang M, and Zou MH. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 282: 9777-9788, 2007.
59. Zhang Y, Handy DE, and Loscalzo J. Adenosine-dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circ Res 96: 831-837, 2005